Home
>
National Drug Code (NDC)
>
Zytiga
Zytiga - 57894-150-12 - (abiraterone acetate)
Drug Information of Zytiga
| Product NDC: | 57894-150 |
| Proprietary Name: | Zytiga |
| Non Proprietary Name: | abiraterone acetate |
| Active Ingredient(s): | 250 mg/1 & nbsp; abiraterone acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zytiga
| Product NDC: | 57894-150 |
| Labeler Name: | Janssen Biotech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202379 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110428 |
Package Information of Zytiga
| Package NDC: | 57894-150-12 |
| Package Description: | 120 TABLET in 1 BOTTLE (57894-150-12) |
NDC Information of Zytiga
| NDC Code | 57894-150-12 |
| Proprietary Name | Zytiga |
| Package Description | 120 TABLET in 1 BOTTLE (57894-150-12) |
| Product NDC | 57894-150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | abiraterone acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110428 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Biotech, Inc. |
| Substance Name | ABIRATERONE ACETATE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC] |
